Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452822) titled 'Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease' on March 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Condition:
Arteriovenous Fistula Stenosis
Intervention:
Biological: Human umbilical cord mesenchymal stem cells injection
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date ...